ETF收评：港股创新药ETF领涨4.72%，黄金股ETF基金领跌1.26%
news flash·2025-06-09 07:03
Group 1 - The Hong Kong innovative drug ETF (513120) led the gains with an increase of 4.72% [1] - The Hang Seng Medical ETF (159506) rose by 4.66% [1] - The Hong Kong innovative drug ETF fund (520700) increased by 4.65% [1] Group 2 - The gold stock ETF fund (159315) was the biggest loser, declining by 1.26% [1] - The gold ETF AU (518860) fell by 1.16% [1] - The Shanghai Gold ETF (159830) decreased by 1.12% [1] Group 3 - A-share accounts can buy Hong Kong stocks with T+0 trading without the need for Hong Kong Stock Connect [1]